agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
1.970
+0.090 (4.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
agilon health Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for agilon health stock have an average target of 4.38, with a low estimate of 1.75 and a high estimate of 9.00. The average target predicts an increase of 122.34% from the current stock price of 1.97.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for agilon health stock from 18 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 10 | 10 | 10 | 9 | 11 | 12 |
| Sell | 1 | 1 | 1 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Total | 15 | 15 | 15 | 16 | 17 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Macquarie | Macquarie | Hold Initiates $3 | Hold | Initiates | $3 | +52.28% | Dec 16, 2024 |
| Bernstein | Bernstein | Hold Initiates $2.5 | Hold | Initiates | $2.5 | +26.90% | Dec 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $3 | Buy | Reiterates | $3 | +52.28% | Nov 19, 2024 |
| Citigroup | Citigroup | Strong Sell Maintains $2.5 → $1.75 | Strong Sell | Maintains | $2.5 → $1.75 | -11.17% | Nov 13, 2024 |
| Stifel | Stifel | Hold Maintains $7 → $2 | Hold | Maintains | $7 → $2 | +1.52% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
6.11B
from 4.32B
Increased by 41.65%
Revenue Next Year
6.74B
from 6.11B
Increased by 10.30%
EPS This Year
-0.57
from -0.64
EPS Next Year
-0.39
from -0.57
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 6.4B | 8.2B | 10.0B | |||
| Avg | 6.1B | 6.7B | 7.8B | |||
| Low | 5.9B | 5.9B | 6.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 47.6% | 33.5% | 48.6% | |||
| Avg | 41.6% | 10.3% | 15.4% | |||
| Low | 36.5% | -2.9% | -1.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.36 | -0.20 | 0.02 | ||
| Avg | -0.57 | -0.39 | -0.23 | ||
| Low | -0.64 | -0.53 | -0.38 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.